Title

Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy

UMMS Affiliation

Department of Medicine; Division of Oncologic Imaging, Department of Radiology; Department of Pathology; Division of Gastroenterology, Department of Medicine; Division of Hematology Oncology, Department of Medicine

Publication Date

2021-03-15

Document Type

Letter to the Editor

Disciplines

Hematology | Hemic and Lymphatic Diseases | Neoplasms | Oncology | Radiology

Abstract

Our case highlights the importance of recognizing the atypical radiological response of patients with hematological malignancies treated with polatuzumab vedotin or other antibody-drug conjugates.

DOI of Published Version

10.1080/10428194.2021.1894646

Source

Wang X, McIntosh L, Selove WJ, Zivny J, Cerny J. Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy. Leuk Lymphoma. 2021 Mar 15:1-4. doi: 10.1080/10428194.2021.1894646. Epub ahead of print. PMID: 33719894. Link to article on publisher's site

Journal/Book/Conference Title

Leukemia and lymphoma

Related Resources

Link to Article in PubMed

PubMed ID

33719894

Share

COinS